Thurston Springer Miller Herd & Titak’s Guardant Health GH Stock Holding History

Thurston Springer Miller Herd & Titak’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.45K	Hold	43	–	–	﹤0.01%	934
2026 Q1	$3.97K	Sell	43 -262	-86%	-$26.3K	﹤0.01%	1087
2025 Q4	$31.2K	Buy	+305	New	+$27.3K	0.01%	615
2025 Q3	–	Sell	-898	Closed	-$46.7K	–	870
2025 Q2	$46.7K	Sell	898 -186	-17%	-$8.31K	0.01%	686
2025 Q1	$46.2K	Hold	1,084	–	–	0.01%	653
2024 Q4	$33.1K	Buy	1,084 +223	+26%	+$6.27K	0.01%	623
2024 Q3	$19.7K	Buy	861 +19	+2%	+$538	0.01%	832
2024 Q2	$24.3K	Buy	+842	New	+$19.6K	0.01%	757

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Thurston Springer Miller Herd & Titak's GH Position: Q2 2026 in Review

Thurston Springer Miller Herd & Titak held its Guardant Health (GH) position steady in Q2 2026 at 43 shares worth $6.45K. The position accounts for ﹤0.01% of the portfolio, ranked #934.

Thurston Springer Miller Herd & Titak first reported a position in GH in Q2 2024 and has held it in 8 quarters since. The position peaked at $46.7K in Q2 2025. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

Thurston Springer Miller Herd & Titak held 43 shares of Guardant Health worth $6.45K as of Q2 2026.
Thurston Springer Miller Herd & Titak left its Guardant Health share count unchanged in Q2 2026.
Guardant Health made up ﹤0.01% of Thurston Springer Miller Herd & Titak's portfolio in Q2 2026, its #934 holding.
Thurston Springer Miller Herd & Titak first reported a position in Guardant Health in Q2 2024 and has held it in 8 quarters since.
Thurston Springer Miller Herd & Titak's Guardant Health position peaked at $46.7K in Q2 2025.
597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Thurston Springer Miller Herd & Titak's 13F filing for Q2 2026, filed 8 Jul 2026.